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Trop2 has been linked to cell proliferation in numerous studies. Human TROP2 (also known as TACSTD2) gene expression is highly upregulated in colorectal, pancreatic, esophageal, oral, breast, uterine, and ovarian cancers (1, 10 -12, 26, 28, 29, 41, 43) . TROP2 expression is 20-fold higher in human lung carcinomas than in normal lung tissue (33) and is a prognostic marker of lung adenocarcinoma (19) . The ectopic expression of TROP2 increases the proliferation of various transformed and immortalized cell lines (4, 36, 43) . In addition to its role in promoting cell proliferation, TROP2 has also been associated with cell migration. Overexpression of murine TROP2 in Panc02 cells increases cell migration (4) and TROP2 expression is linked to increased metastasis in human tumors in vivo (11, 28) . These studies suggest that Trop2 regulates cell proliferation and migration in cancer cells and when combined with our data suggests that it may also regulate fetal lung growth and development. We hypothesized that Trop2 not only regulates lung cell proliferation but is also an important regulator of fibroblast motility in the fetal lung.
Our aims were 1) to determine the effects of TROP2 knockdown and overexpression on cell motility in fetal lung fibroblasts in culture and 2) to identify likely cellular and molecular mechanisms by which Trop2 regulates fetal lung fibroblast proliferation and motility.
METHODS
Isolation of fetal lung fibroblast cells. All animal usage was approved by the Monash University Animal Welfare committee. At embryonic day 19 (E19; term ϳE22), pregnant Sprague-Dawley rats were humanely killed by CO 2 inhalation. Primary fetal lung fibroblasts were isolated by differential attachment as previously described (25) . Cells were seeded onto 100-mm cell culture dishes or on glass coverslips in 24-well cell culture dishes, at a density of 1.3 ϫ 10 4 cells/cm 2 in Waymouth's MB 752/1 medium (containing 10% heatinactivated fetal calf serum, 50 U/ml penicillin, and 50 g/ml streptomycin) and incubated overnight at 37°C in 5% CO 2. TROP2 siRNA transfection. Primary fetal lung fibroblasts isolated as described above were transfected with either TROP2 siRNA (Stealth RNAi duplex 5=-CGACAGACCGAGCCUUCAACCACU-3=; Invitrogen) or control siRNA matched for TROP2 siRNA GC content (33.3 nM; Stealth RNAi High GC negative control duplex, Invitrogen), with Lipofectamine RNAiMax transfection reagent (Invitrogen) diluted in Opti-MEM I reduced-serum medium (Invitrogen). Cells were incubated with siRNA duplexes for 6 h in Waymouth's MB 752/1 medium without antibiotics or fetal calf serum. After 24 h, the medium was replaced with medium containing fetal calf serum, penicillin, and streptomycin. After 48 h cells were either collected for RNA, fixed for histological and immunocytochemical analysis, or imaged to measure cell motility. Experiments were performed in triplicate, except where stated otherwise, and each experiment was repeated two to three times for each analysis using cells from different litters.
TROP2 overexpression. Primary fetal lung fibroblasts were transfected with commercially available DDK-tagged plasmids containing the rat TROP2 gene sequence (pCMV6 Rat TROP2-ORF-DDK, Origene) or a control plasmid that lacked TROP2 (pCMV6-AN-DDK vector, Origene). After overnight culture, cells were transfected with plasmids (1 g/7.5 cm 2 ) by using Lipofectamine LTX with PLUS reagent (Invitrogen) diluted in Opti-MEM I reduced-serum medium (Invitrogen). Cells were incubated with plasmids for 24 h in Waymouth's MB 752/1 medium without antibiotics or fetal calf serum. After 24 h, medium was replaced with medium containing fetal calf serum, penicillin, and streptomycin. After 48 h, cells were treated with the antibiotic Geneticin (G418; Invitrogen) to select for positively transfected cells. Cells were retreated with G418 every 2-3 days for 2 wk, to allow for stable transfection, and were then collected for analysis. Experiments were performed in triplicate, except where stated otherwise, and each experiment was repeated two to four times for each analysis using cells from different litters.
RNA extraction and real-time PCR. Real-time PCR was performed as previously described (24) . Briefly, total RNA was isolated from fetal lung fibroblasts by use of the RNeasy mini RNA extraction kit (Qiagen). Total RNA (1 g) was then reverse transcribed with Superscript III Reverse Transcriptase (Invitrogen). Relative expression of TROP2 as well as the lipofibroblast markers Parathyroid hormone 1 receptor (PTH1r), peroxisome proliferator-activated receptor gamma (PPAR␥), and Thy-1 were quantified by real-time PCR with the housekeeping gene ribosomal protein 29 (Rps29) by the ⌬Ct method of analysis and expressed as a fold change relative to the mean level in the control groups; the primer sequences used to amplify these genes are shown in Table 1 .
Cellular senescence assay. Cellular senescence was detected via the senescence-associated ␤-galactosidase (SA-␤gal) activity protocol (5) . Cells were fixed in 2% formaldehyde-0.2% glutaraldehyde diluted in PBS for 5 min at room temperature, rinsed twice in PBS, and incubated in staining solution (40 mM citric acid-sodium phosphate buffer, 5 mM K 4[Fe(CN)6]·3H2O, 5 mM K3[Fe(CN)], 150 mM sodium chloride, 2 mM magnesium chloride, and 1 mg/ml X-gal diluted in distilled water) overnight at 37°C in the dark. Cells were then rinsed twice in PBS and once in methanol and were air dried. Digital images of cells were acquired by using a Zeiss Axiovert 40C phase-contrast microscope, with positive blue staining indicating cell senescence; this protocol was confirmed by use of senescent primary human uterine stromal cells (a gift from Associate Professor Caroline Gargett, Monash University), included in all experiments.
Hematoxylin and eosin staining. To assess cell morphology, cells were grown on glass coverslips, fixed in 4% paraformaldehyde (PFA), then stained with hematoxylin and eosin (H&E) as previously described (42) .
Oil Red O staining. Cells were grown on glass coverslips, fixed in 4% PFA, then washed in 30% isopropanol for 5 min. Cells were incubated in filtered Oil Red O (1 mg/ml in 65% isopropanol) for 20 min, then washed in 30% isopropanol for 5 min, rinsed in distilled water, and counterstained in hematoxylin for 1 min. Cells were then rinsed in distilled water and mounted onto glass slides with glycerol.
Immunocytochemistry. Primary cell cultures grown on glass coverslips were fixed in 4% PFA for 20 min at room temperature and washed in 1ϫ PBS (5 min). For intracellular proteins, cells were first permeabilized in 0.1% Triton X-100 (diluted in 1ϫ PBS; 5 min), then washed again in 1ϫ PBS (5 min). Nonspecific binding was blocked by incubation with 10% BSA (diluted in PBS) for 1 h at room temperature. Cells were then incubated with the primary antibody ( Table 2) overnight at 4°C and then washed in PBS-0.1% Tween 20 (PBST; Rat  NM_001009540  5=-CACCGCTGCTACTGCTACTG-3=  89  5=-GACGGTCATCTTGTTGGTAGG-3=  PPAR␥  Rat  NM_013124  5=-GAAGAACCATCCGATTGAAG-3=  140  5=-AAACCTGATGGCATTGTGAG-3=  PTH1r  Rat  NM_020073  5=-GCAGCCAACATAATGGAGTC-3=  57  5=-CTTCCCTGACGTAGATGCTG-3=  Thy-1  Rat  NM_012673  5=-GAGCTATTGGCACCATGAAC-3=  57  5=-GCAAGACTGAAAGCAGGAGA-3=  Rps29 Rat NM_012876 5=-CAGGGTTCTCGCTCTTGC-3= 90 5=-CTGACGGAAGCACTGTCG-3= 3 ϫ 5 min) before they were incubated with the secondary antibody ( Table 2) for 1 h at room temperature. Single-label immunocytochemistry. Cells that had been incubated with fluorescent antibodies [Trop2, vimentin, ␣-smooth muscle actin (␣-SMA), vinculin, and cortactin] were mounted in antifade gold fluorescent mounting medium with DAPI (Invitrogen) by using Superfrost Plus glass slides and were kept at 4°C in the dark until imaged. Cells incubated with biotinylated antibodies (pan-cytokeratin, Ki-67, ␣-SMA, DDK) were incubated for 45 min at room temperature with streptavidin-biotinylated horseradish peroxidase complex (1:200 in PBS; GE Healthcare), washed with PBS (3 ϫ 5 min), and then incubated with metal enhanced diaminobenzidine (Thermo Scientific) in peroxide substrate buffer (1 in 10 dilution; Thermo Scientific) for 10 min. Cells were then counterstained with hematoxylin and mounted in DPX by using Superfrost Plus glass slides. Nonspecific binding was assessed by omission of the primary antibody.
Double-label immunofluorescence. Cells were washed in PBST 3 ϫ 5 min, incubated with Dako serum-free protein block for 10 min at room temperature to block nonspecific binding, then washed in PBS (3 ϫ 5 min) and then incubated in the Cy3-vimentin primary antibody (1:1,000) for 1 h or Alexa Fluor 488 phalloidin (1:1,000) for 10 min at room temperature. Cells were rinsed in PBS (ϫ3) and then mounted in Antifade gold fluorescent mounting medium with DAPI (Invitrogen) by using Superfrost Plus glass slides. Specificity of the antibodies was determined by individually omitting each of the primary antibodies.
Microscopy. Immunofluorescent labeling of cells was visualized and digital images were captured by use of a Nikon C1 confocal laser scanning microscope system. Fluorophores were excited specifically with 408-, 488-, 561-, or 637-nm lasers and fluorescence detected with 450/35-, 515/30-, 605/75-, and 700/100-nm filters, respectively. Zstack analysis and cell counts were performed with MacBiophotonics ImageJ. To determine cell purity and phenotype, cells were viewed at high power and digital images were captured. The total number of cells and the number of cells positive for vimentin, pan-cytokeratin, Oil Red O, and ␣-SMA per field of view were counted from at least five random fields of view per coverslip and from triplicate samples for each group, ensuring that at least 850 nuclei/treatment were counted in total. The number of positive cells was expressed as a percentage of the total number of cells counted.
Cell motility assay. Live cells were viewed with a Leica LX microscope via phase-contrast microscopy. Six fields of view per well were selected randomly and each position was imaged every 20 min over 24 h (48 -72 h after transfection). Images were analyzed with Imaris image analysis software (Bitplane Scientific Software) and cell motility was quantified by superimposing 1-cm 2 gridlines over the images (ϫ10 magnification). Cell motility was manually tracked in three to four fields of view per well over 24 h and the number of times that each cell moved across a gridline was recorded; the movements of Ͼ365 cells were analyzed per treatment in each experiment. Cells were considered to have moved from one grid to another when Ͼ50% of the nucleus had moved across the gridline. Other events that were recorded were cell division (clearly observed division of cell nucleus and cytoplasm) and cell death/detachment (clear observation of cells shrinking and detaching from the plate). For each position, the total number of cells that were motile during the 24 h time period was expressed as a percentage of total cells. The degree of motility was expressed as the average number of gridlines that cells moved across during the 24 h period, excluding cells that were not motile. Cells that died and detached during the 24 h were excluded from motility analysis.
Western blots. Cells were cultured in 100-mm dishes and transfected with control siRNA, TROP2 siRNA, or transfection reagent. Medium was removed 48 h after transfection and cells were washed in cold PBS. Cells were then lysed directly in the culture dishes by using 1ϫ cell lysis buffer (50 mg/ml; Cell Signaling Technologies) with phenylmethylsulfonyl fluoride (PMSF; 10 l/ml of cell lysis buffer) and protease inhibitor cocktail (1 mM; Sigma) as per manufacturer's instructions. Total protein content of the supernatant was determined via the Lowry method using a Bio-Rad DC (detergent compatible) Protein Assay kit. Protein samples (40 g) in 4ϫ SDS sample buffer (Novagen) were heat denatured, separated by 10% SDS-polyacrylamide (SDS-PAGE) gel electrophoresis, and transferred to nitrocellulose membrane (Protran BA-85 nitrocellulose membrane, Schleicher & Schuell). Successful transfer of the proteins to the membrane was confirmed by staining with Ponceau S solution.
Membranes were blocked in 5% skim milk powder for 1 h at room temperature, then incubated in primary antibody (Table 3) http://ajplung.physiology.org/ dividing the corrected average density of the phosphorylated band by the corrected average density of the total protein of interest.
RESULTS

Fibroblast culture characteristics.
The majority (98.5 Ϯ 0.8%) of cells in our primary cultures were fibroblasts that showed a typical stellate morphology with an elongated spindlelike structure and were positively labeled for the mesenchymal cell marker vimentin (Fig. 1A) . The nonmesenchymal cells present in these primary cultures (1.5 Ϯ 0.4%) stained positive for pan-cytokeratin, an epithelial cell marker (Fig. 1C) . Oil Red O staining was used to label and identify lipofibroblasts (Fig. 1, G and H, and Table 4 ). After 1 h in culture, the vast majority (95.3 Ϯ 2.8%) of cells were positive for Oil Red O staining. There was a small but nonsignificant decrease (81.7 Ϯ 11.7%) in the percentage of Oil Red Ostained fibroblasts at 48 h in culture. An ␣-SMA antibody was used to label and identify fibroblasts that had differentiated into myofibroblasts. No fetal lung fibroblasts were positively stained for ␣-SMA 1 h after seeding, but the vast majority (91.7 Ϯ 5.6%) stained positive for ␣-SMA after 48 h in culture (Fig. 1, E and F, and Table 4 ). PTH1r, PPAR␥, and Thy-1 were used as markers of lipofibroblasts (30, 35, 40) . Expression of all three genes decreased substantially between 24 h (PTH1r 1.0 Ϯ 0.7; PPAR␥ 1.0 Ϯ 0.7; Thy-1 1.0 Ϯ 0.5) and 48 h (PTH1r 0.2 Ϯ 0.05; PPAR␥ 0.1 Ϯ 0.001; Thy-1 0.3 Ϯ 0.1) in culture; however, because of the high level of variability in the mRNA levels of all three genes at 24 h in culture, the difference between 24 h and 48 h was not statistically significant (Fig. 1I) .
Trop2 localization. Trop2 was localized around the nucleus and in the lamellipodia of cultured fibroblasts (Fig. 2 ). Trop2 could be observed in dividing cells and at the leading edge of the cell (Fig. 2C) . Trop2 labeling could be seen in 89.6 Ϯ 1.8% of all primary cultured fibroblasts (Fig. 2) . TROP2 was localized to the lamellipodia of all of the labeled cells and was also found to have a perinuclear localization in 20.9 Ϯ 4.1% of all fibroblasts (Fig. 2D ); all cells with perinuclear localization also had lamellipodia localization.
Knockdown of TROP2. TROP2 mRNA levels were significantly decreased by ϳ75% in cultured fetal lung fibroblasts following transfection of cells with TROP2 siRNA (0.25 Ϯ 0.08; P Ͻ 0.05) compared with cells transfected with control siRNA (1.00 Ϯ 0.25) or transfection reagent only (1.56 Ϯ 0.16; Fig. 3A ) (25) . Following treatment with TROP2 siRNA there was also a significant decrease in the percentage of cells labeled with the Trop2 antibody (23.3 Ϯ 2.4%; P Ͻ 0.05; Fig.  3B ), compared with cells treated with control siRNA (76.9 Ϯ 6.4%) or transfection reagent only (80.1 Ϯ 5.3%). Representative low-and high-power images showing the presence and absence of Trop2 labeling (red fluorescence, sometimes appearing yellow when colocalized with actin, which is labeled green) are shown for fibroblasts treated with control siRNA (Fig. 3C ), TROP2 siRNA (Fig. 3D) , and transfection reagent only (Fig. 3E ). Similar to our previous study (25), we confirmed that the percentage of proliferating fibroblasts was significantly reduced in TROP2 siRNA-transfected cells 2 ), although this was not statistically significant (P ϭ 0.09; Fig. 4B ). We also confirmed that there was no difference in viability between cells transfected with control siRNA (98.2 Ϯ 1.0%), transfection reagent only (98.5 Ϯ 0.4%), or TROP2 siRNA (99.2 Ϯ 0.2%; Fig. 4C ). No ␤-galactosidase staining was observed in cells transfected with control siRNA, TROP2 siRNA or treated with transfection reagent only (Fig. 4, D-G) , although it was present in the primary human uterine stromal cells grown to senescence that were used as positive controls.
The morphology of fetal lung fibroblasts is altered by TROP2 knockdown. In cells treated with TROP2 siRNA, the small proportion of cells that did contain Trop2 retained the normal fibroblast cell morphology, with Trop2 localized to the lamellipodia and around the nucleus. In comparison, cells treated with TROP2 siRNA that lacked Trop2 labeling exhibited abnormal morphology with no lamellipodia (Fig. 3D ) within 48 h of transfection. This resulted in three morphological phenotypes (Fig. 5) . The majority of cells (50.8 Ϯ 10.5%) had lost their stellate appearance and had become flatter and circular when viewed from above. In addition, some cells (10.4 Ϯ 2.6%) transfected with TROP2 siRNA became smaller and more rounded and were characterized by a dark, punctate TROP2 knockdown impairs cell motility. There was a trend for a decrease in the number of cells that were motile following transfection with TROP2 siRNA (67.6 Ϯ 7.2%; P ϭ 0.07) compared with cells treated with control siRNA (84.7 Ϯ 0.4%) and transfection reagent only (89.4 Ϯ 1.7%; Fig. 6 and Supplemental Fig. S1 ; supplemental material for this article is available online at the Journal website). Of the fibroblasts that were motile, there was a significant decrease in the degree of cell motility, measured as the mean number of gridlines that cells moved across, in cells transfected with TROP2 siRNA (2.2 Ϯ 0.2 gridlines; P Ͻ 0.001), compared with cells transfected with control siRNA (3.2 Ϯ 0.2 gridlines) or transfection 
9%).
Cytoskeletal changes following TROP2 knockdown. To investigate the changes in cell architecture following knockdown of TROP2 with siRNA, components of the cytoskeleton were assessed (Fig. 7) .
Vimentin distribution. In fibroblasts treated with control siRNA and transfection reagent only, the intermediate filament vimentin was distributed abundantly throughout the cell cytoplasm, continuing into the stellate extensions. In cells transfected with TROP2 siRNA, vimentin filaments were substantially reorganized and were primarily located around the nucleus (Fig. 7, C and D) . These changes were observed in both the large, flatter cells and the small rounded cells.
Actin distribution. Cells were stained with phalloidin, an F-actin marker, to identify lamellipodia formation. In cells transfected with TROP2 siRNA, lamellipodia were absent and F-actin was concentrated around the cell periphery, with very little F-actin within the remainder of the cytoplasm (Fig. 7A) , compared with control cells. These changes were observed in both the large, flatter cells and the small rounded cells. In cells treated with either control siRNA or transfection reagent only, normal lamellipodia were present and F-actin fibers were distributed throughout the cell cytoplasm.
␣-SMA distribution. In fibroblasts transfected with control siRNA or transfection reagent only, ␣-SMA was organized into thin fibers, extending throughout the cytoplasm with light staining in the lamellipodia. In fibroblasts transfected with TROP2 siRNA, ␣-SMA staining was substantially redistributed primarily to the cell cortex with very little ␣-SMA extending throughout the cytoplasm (Fig. 7C) . This reorganization occurred in both the large, flatter cells and the small rounded cells.
Vinculin localization. Vinculin staining was used as a marker of focal adhesions and focal complexes. Focal adhe- sions are flat, elongated adhesion sites, which provide strong adhesion to the substrate and allow migrating cells to "pull or push" themselves over the substrate (14) . Focal complexes are small, dotlike adhesions located at the edge of lamellipodia; these may be disassembled as the lamellipodia withdraws or they can mature into focal adhesions to form the leading edge of a migrating cell (14) . In cells transfected with control siRNA or transfection reagent only, vinculin staining was localized to focal adhesions across the basal surface of the cells, aligning with the direction of cell extensions. Focal complexes were also observed, localized to the lamellipodia. In cells treated with TROP2 siRNA, vinculin was localized to large focal adhesions, which were observed around the basal periphery of the cells (Fig. 7B) . This was observed in both large flatter cells and smaller rounded cells. No focal complexes were observed following TROP2 knockdown (Fig. 7B) . Additionally, in the smaller rounded cells, vinculin was reorganized into podlike regions around the periphery and across the top of the cells (not shown), similar to the cortactin localization in those cells (Fig. 7D) .
Cortactin localization. In fibroblasts transfected with control siRNA or transfection reagent only, cortactin staining was very faint and was distributed throughout the basal surface of the cell, with an increased density in the lamellipodia (Fig. 7D) . In fibroblasts transfected with TROP2 siRNA, cortactin staining was much stronger. In the larger flatter cells, there was also an increase in staining at the basal periphery of the cytoplasm, rather than being evenly distributed across the basal surface (data not shown). In the small rounder cells, cortactin was redistributed to dense pods at the periphery of the cells and in some cases extending across the top of the cell (Fig. 7D) . The numbers of cells with cortactin-positive pods were similar in cells treated with control siRNA (3.6 Ϯ 1.9%) and transfection reagent only (1.6 Ϯ 0.2%) but were significantly increased (to 22.3 Ϯ 8.3%) in fibroblasts transfected with TROP2 siRNA.
TROP2 knockdown alters ERK signaling. Cells transfected with TROP2 siRNA had a significant decrease in the total level of ERK1 (p44) (19.5 Ϯ 1.9%) compared with cells transfected with control siRNA (100.0 Ϯ 6.1%) and transfection reagent only (113.6 Ϯ 4.4%; Fig. 8A ). There was no change in the total level of ERK 2 (p42) between cells treated with TROP2 siRNA (101.5 Ϯ 6.1%), control siRNA (100.0 Ϯ 4.4%), and transfection reagent only (112.1 Ϯ 6.5%). There was also a significant decrease in the proportion of total ERK1 that was phosphorylated in cells transfected with TROP2 siRNA (14.0 Ϯ 2.7%) compared with control siRNA (100.0 Ϯ 17.1%) and transfection reagent only (162.8 Ϯ 21.5%; Fig. 8B ). The relative proportion of ERK2 that was phosphorylated tended to be decreased (P ϭ 0.06) in cells treated with TROP2 siRNA (58.8 Ϯ 7.7%) compared with control siRNA (100.0 Ϯ 3.8%) and transfection reagent only (119.8 Ϯ 13.5%).
There was no change in total PLC␥2 protein levels between cells transfected with TROP2 siRNA (64.9 Ϯ 20.3%), control siRNA (100.0 Ϯ 2.4%), or transfection reagent only (130.3 Ϯ 13.2%; Fig. 8C ), but the proportion of PLC␥2 that was phosphorylated tended (P ϭ 0.06) to be higher in cells treated with C-raf 100 Ϯ 3.1%), or transfection reagent only (B-raf 96.4 Ϯ 0.7%; C-raf 122.2 Ϯ 13.8%; Fig. 8C) .
Overexpression of TROP2. To confirm that the changes identified following TROP2 siRNA were due to a specific effect of TROP2 and not to an off-target siRNA effect, we transfected primary fetal lung fibroblasts with a DDK-tagged TROP2 overexpression vector to increase TROP2 levels. There was no difference in the proportion of cells positive for DDK between cells transfected with TROP2-DDK (90.5 Ϯ 2.3%) or control DDK (89.9 Ϯ 1.5%) vectors (Fig. 9, A and B) , indi- cating efficient and stable transfection of both vectors. TROP2 mRNA levels were significantly increased in cells transfected with the TROP2-DDK vector (43.7 Ϯ 4.6) compared with cells transfected with the control DDK vector (1.0 Ϯ 0.8; P ϭ 0.0008; Fig. 9D ). TROP2 overexpression induced a 40% increase in the proportion of cells proliferating (29.5 Ϯ 1.1%) compared with cells transfected with the control vector (21.1 Ϯ 1.6%; P Ͻ 0.01, Fig. 9E ). TROP2 overexpression also significantly increased the total percentage of cells that were motile (64.0 Ϯ 2.0% TROP2 vs. 44.6 Ϯ 3.2% control; P Ͻ 0.01; Fig. 9F ). In the cells that were motile, TROP2 overexpression significantly increased the degree of motility as determined by the mean number of gridlines crossed per cell (2.1 Ϯ 0.2 TROP2 vs. 1.6 Ϯ 0.1 control; P Ͻ 0.001; Fig. 9G ).
DISCUSSION
In the present study, we demonstrated that TROP2 knockdown in primary fetal lung fibroblasts significantly alters cell morphology and impairs cell proliferation and motility. These effects of the Trop2 protein were likely mediated by alterations in ERK1 and ERK2 signaling and by the effect of Trop2 on lamellipodia formation and the reorganization of proteins involved in cell migration and adhesion. To ensure that the effects of TROP2 siRNA were specific and not due to off-target effects of siRNA, we overexpressed TROP2 and showed an increase in TROP2 expression that was associated with an increase in cell proliferation and cell motility. The proliferation and migration of fibroblasts in the distal lung are vital for fetal lung growth and development (2, 22) , and this study indicates that Trop2 may be an important regulator of these processes.
We found that a 70 -80% knockdown of TROP2 induced an ϳ50% decrease in the proportion of proliferating fetal lung fibroblasts, which supports our previous finding (25) . This reduction in cell proliferation, together with the morphological changes that reduce overall cell size, was likely responsible for the slight tendency for the cell density to be reduced. When TROP2 was overexpressed there was an increase in cell proliferation. Taken together our data clearly demonstrate that Trop2 is an important regulator of proliferation in cultured fetal lung fibroblasts, which is consistent with its role in tumor cells (4, 36) . Although TROP2 knockdown decreased cell proliferation, it did not cause the cells to become senescent, as determined by a lack of senescence-associated ␤-galactosidase staining and the absence of other markers for senescence including increased cell size (17) and increased longer, denser vimentin (27) . Vimentin became shorter and less dispersed in response to TROP2 knockdown.
Cell motility and migration involve lamellipodia extension and focal complex and focal adhesion formation at the lamellipodia. Actin molecules in the focal adhesions and cytoskel- eton contract toward the leading edge of the cell, whereas focal adhesions at the trailing edge disassemble, promoting translocation of the cell body toward the lamellipodia. This process involves coordination of many fibers and proteins, including actin, vimentin, cortactin, and vinculin. Knockdown of TROP2 impaired lamellipodia formation and altered the distribution of vimentin, cortactin, and vinculin, suggesting that Trop2 plays a pivotal role in regulating the motility of fetal lung fibroblasts by regulating the distribution and abundance of the migration machinery in the cells.
In control cells Trop2 was localized to lamellipodia but lamellipodia were absent following TROP2 knockdown, suggesting that Trop2 regulates lamellipodia formation. This is supported by the changes in cortactin, which binds to actin and regulates lamellipodia persistence and migration (3, 20, 32) . Inactive cortactin is diffuse throughout the cytoplasm but when activated it localizes to sites of actin polymerization, such as lamellipodia. In control cells cortactin was barely visible in the cytoplasm with an increase in density in lamellipodia, but, following TROP2 knockdown, cortactin was abnormally localized into podlike structures around the edge and over the apical surface of the cells.
In addition to the loss of lamellipodia following TROP2 knockdown, there was a substantial reorganization of adhesion structures. Focal adhesions and focal complexes are sites of cell-matrix adhesion, connecting the cytoskeleton to integrin cell adhesion molecules (14) and enabling cell migration. In fibroblasts transfected with TROP2 siRNA there were no focal complexes and focal adhesions were only present around the cell periphery. The absence of focal adhesions is likely due to alterations in cortactin and vinculin localization since both of these proteins regulate the production of focal adhesion complexes (3, 6) . The lack of focal complexes and abnormally localized focal adhesions in fibroblasts following TROP2 knockdown suggests that Trop2 regulates lamellipodia formation, focal adhesion formation, and cell motility.
Another factor that may have contributed to the altered focal adhesions and impaired cell migration following TROP2 knockdown is the vimentin intermediate filament network, which regulates focal adhesion size and strength (24, 39) . The vimentin network was widely dispersed throughout the cytoplasm in control cells but was located around the nucleus following TROP2 knockdown. Perinuclear localization of vimentin, similar to that seen following TROP2 knockdown, has been observed in a number of cells with decreased migration capacity (9, 13) , and vimentin-deficient fibroblasts and endothelial cells also exhibit decreased migration and cell proliferation (8, 24, 45) .
TROP2 has previously been shown to regulate the migration of epithelial Panc02 cells (4) and has been positively correlated to metastasis and invasion in colorectal and pancreatic cancer (11, 28) . In contrast, the ectopic expression of TROP2 in adult siRNA (solid bar), and transfection reagent only (shaded bar) were labeled for total and phosphorylated ERK1/2 and PLC␥2, total B-raf and C-raf, as well as loading protein ␤-actin. There was no change in levels of total or phosphorylated PLC␥2, total B-raf, or total C-raf between cells treated with control siRNA, TROP2 siRNA, or transfection reagent only.
canine kidney epithelial (MDCK) cells reduced cell migration and there was no correlation between TROP2 expression and cell proliferation in the early embryonic kidney (38) . These findings may be specific to kidney cells since they contrast with our present and previous findings in fetal lung fibroblasts in vitro, in the late-gestation fetal lung in vivo (25) , and with most studies that have investigated the role of TROP2 in tumorigenesis (4, 36, 43) . Knockdown of TROP2 significantly decreased the overall abundance and relative proportion of phosphorylated ERK1/2, but it did not alter the levels or activation of other proteins in the ERK signaling pathway, including PLC␥2, B-raf, or C-raf. ERK1/2 signaling is strongly associated with cell proliferation and migration (31) , suggesting that the effect of Trop2 on cell motility that we observed may be due to alterations in ERK signaling. It is well established that Trop2 can alter the ERK signaling pathway. However, TROP2 has been found to both increase and decrease ERK levels and activation depending on cell type and the duration of TROP2 overexpression (4, 15, 21, 37, 44) .
On the basis of our findings that TROP2 knockdown inhibits, whereas TROP2 overexpression increases, the motility of fetal lung fibroblasts in culture, we speculate that Trop2 may also regulate the migration of fetal lung myofibroblasts in vivo.
The majority of fibroblasts used in this study were positive for Oil Red O staining after 1 h in culture and completely lacked ␣-SMA staining, suggesting that they were primarily interstitial lipofibroblasts at the time of isolation and that none of the isolated cells were smooth muscle cells (35) . After 48 h in culture most fibroblasts appear to have differentiated into a myofibroblast phenotype, as indicated by a decrease in the expression of lipofibroblast marker genes and the presence of abundant ␣-SMA staining ( Table 4 ). The differentiation of fibroblasts into myofibroblasts in culture is common in fibroblasts isolated from many organs, including the lung (7, 46) . We have previously shown that Trop2 is localized to myofibroblasts in the developing rat lung (25) and myofibroblasts are vital for normal lung development in the fetus (22) . During alveolar development, myofibroblasts localize to the primary septa where the secondary septal crests arise. As secondary septation occurs, the myofibroblasts synthesize and secrete elastin at the tip of the elongating septae, which drives the further extension of the septal crest (18) . The impairment of proliferation and motility following TROP2 knockdown, and enhancement of proliferation and motility following TROP2 overexpression, in fetal lung fibroblasts suggests that Trop2 is likely to play a pivotal role in regulating fetal lung myofibroblast proliferation, migration, and alveolarization. TROP2 knockout mice have recently been generated (44) . Although these mice survive to adulthood with no obvious developmental abnormalities, lung tissue has not been examined at any age (44) . Thus subtle changes in lung development may exist that have not been identified. For example, the loss of TROP2 during fetal life would be expected to reduce the proliferation of fetal lung fibroblasts, which may reduce overall lung growth but may also lead to a thinner air-blood tissue barrier, which would improve rather than impair gas exchange at birth. We have shown that TROP2 knockdown decreases the proliferation and motility of fetal lung fibroblasts and that TROP2 overexpression increases the proliferation and motility of fetal lung fibroblasts. TROP2 knockdown also caused the loss of lamellipodia and focal complexes and altered the distribution of focal adhesions similar to those seen in nonmigratory cells. In addition, various factors regulating lamellipodia and focal adhesions/complexes were mislocalized following TROP2 knockdown, including vimentin, vinculin, and cortactin. These changes in the cytoskeleton, together with changes in ERK1/2, likely mediate the effect of Trop2 on cell motility and may also contribute to the reduction in cell proliferation that occurs following TROP2 knockdown in these cells. Since the fibroblasts in this study adopted a myofibroblast phenotype, we speculate that Trop2 may regulate the migration of fetal lung fibroblasts along the developing alveolar septa. The role of Trop2 in the in vivo regulation of alveolarization warrants further investigation. The data presented here make Trop2 an attractive candidate for coordinating fetal lung growth and alveolarization.
